Advertisement

Benign Breast Disease in Elderly Women and Men

  • Kay O. Lovig
  • Barbara A. Ward
Chapter

Abstract

Familiarity with breast microanatomy and physiology aids in understanding benign breast physiology. The female breast is composed of ductal and lobular units. The main breast ducts arise from lactiferous sinuses in the nipple and divide several times to form small ducts and then the smallest ductal elements, or “ductules,” which in fact form the lobular unit of the breast. The ductules also divide and terminate blindly with club-shaped endings. The ductules are sensitive to hormone stimulation; during pregnancy, they proliferate and form the alveolar components of the breast [1].

Keywords

Luteinizing Hormone Hormone Replacement Therapy Breast Density Invasive Lobular Carcinoma Breast Pain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Parks AG (1959) The microanatomy of the breast. Ann R Coll Surg 25:235–251Google Scholar
  2. 2.
    Anbazhagan R, Bartek J, Monaghan P, Gusteron BA (1991) Growth and development of the human infant breast. Am J Anat 192:407–417PubMedCrossRefGoogle Scholar
  3. 3.
    Reyniak JV (1979) Endocrine physiology of the breast. J Reprod Med 22(6):303–309PubMedGoogle Scholar
  4. 4.
    Bando H et al (1991) Impaired secretion of growth hormone-releaseing hormone, growth hormone and IGF-1 in elderly men. Acta Endocrinol 124:31–33PubMedGoogle Scholar
  5. 5.
    Rudman D et al (1981) Impaired secretion of growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 67:1361–1369PubMedCrossRefGoogle Scholar
  6. 6.
    Waldhauser F, Kovacs J, Reiter E (1998) Age-related changes in melatonin levels in humans and its potential consequences for sleep disorders. Exp Gerontol 33:759–772PubMedCrossRefGoogle Scholar
  7. 7.
    Weiner R, Utiger RD, Lew R, Emerson CH (1991) Age, sex and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol 124:364–369Google Scholar
  8. 8.
    Spaulding SW (1987) Age and the thyroid. Endocrinol Metab Clin North Am 16:1013–1025PubMedGoogle Scholar
  9. 9.
    Pedrazzoni M et al (1988) Calcitonin levels in normal women of various ages evaluated with a new sensitive radioimmunoassay. Horm Metab Res 20:118–119PubMedCrossRefGoogle Scholar
  10. 10.
    Nafziger AN, Bowlin SJ, Jenkins PL, Pearson TA (1998) Longitudinal changes in dehydroepiandrosterone concentrations in men and women. J Lab Clin Med 131:316–323PubMedCrossRefGoogle Scholar
  11. 11.
    Hegstad R et al (1983) Aging and aldosterone. Am J Med 74:442–448PubMedCrossRefGoogle Scholar
  12. 12.
    Khosla S et al (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266–2274PubMedCrossRefGoogle Scholar
  13. 13.
    Sherman BM, West JH, Korenman SG (1976) The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629–636PubMedCrossRefGoogle Scholar
  14. 14.
    Deslypere JP, Vermeulen A (1984) Leydig cell function in normal men: effect of age, life-style, residence, diet and activity. J Clin Endocrinol Metab 59:955–962PubMedCrossRefGoogle Scholar
  15. 15.
    McKinlay SM, Bifano NL, McKinlay JB (1985) Smoking and age at menopause in women. Ann Int Med 103:350PubMedGoogle Scholar
  16. 16.
    Vorherr H (1974) Menopausal mammary involution. In: Vorherr H (ed) The breast. Morphology, physiology, and lactation. Academic, San Diego, CA, pp 215–217Google Scholar
  17. 17.
    Tavossoli FA (1992) Postmenopausal involution (atrophy). In: Tavossoli FA (ed) Pathology of the breast. Elsevier, New York, NY, p 20Google Scholar
  18. 18.
    Lee PA (1975) The relationship of concentrations of serum hormones to pubertal gynecomastia. J Pediatr 86:212PubMedCrossRefGoogle Scholar
  19. 19.
    Moore MP (1996) Male breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman CT (eds) Diseases of the breast, 2nd edn. Lippincott-Raven, Philadelphia, PA, p 859Google Scholar
  20. 20.
    Cordova A, Moschella F (2008) Algorithm for clinical evaluation and surgical treatment of gynaecomastia. J Plast Reconstr Aesthet Surg 61(1):41–49PubMedCrossRefGoogle Scholar
  21. 21.
    Harman SM, Metter EJ, Robin JD et al (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731PubMedCrossRefGoogle Scholar
  22. 22.
    Braunstein GD (1993) Gynecomastia. N Engl J Med 328:490PubMedCrossRefGoogle Scholar
  23. 23.
    Gordon GG, Olivo J, Fereidoon R et al (1975) Conversion of androgens to estrogen in cirrhosis of the liver. J Clin Endocrinol Metab 40:1018PubMedCrossRefGoogle Scholar
  24. 24.
    Evans GF, Anthony T, Turnage RH et al (2001) The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg 181(2):96–100PubMedCrossRefGoogle Scholar
  25. 25.
    DiLorenzo G, Perdona S, DePlacido S et al (2005) Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy. J Urol 174(6):2197–2203CrossRefGoogle Scholar
  26. 26.
    Kuhn J, Roca R, Laudat M et al (1983) Studies on the treatment of idiopathic gynecomastia with percutaneous dihydrotestosterone. Clin Endocrinol 19:513CrossRefGoogle Scholar
  27. 27.
    Parker LN, Gray DR, Lai MK et al (1986) Treatment of gynecomastia with tamoxifen: a double-blind crossover study. Metabolism 35:705PubMedCrossRefGoogle Scholar
  28. 28.
    Dicker AP (2003) The safety and tolerability of low dose irradiation for the management of gynecomastia caused by antiandrogen monotherapy. Lancet Oncol 4:30PubMedCrossRefGoogle Scholar
  29. 29.
    Colombo-Benkmann M, Buse B, Stern J et al (1999) Indications for and results of surgical therapy for male gynecomastia. Am J Surg 178:60PubMedCrossRefGoogle Scholar
  30. 30.
    Smith RL, Pruthi S, Fitzpatrick LA (2004) Evaluation and management of breast pain. Mayo Clin Proc 79(3):353–372PubMedCrossRefGoogle Scholar
  31. 31.
    Fentiman I (2004) Management of breast pain. In: Harris JR, Lippman ME, Morrow M, Osborne CL (eds) Diseases of the breast, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, PA, pp 57–61Google Scholar
  32. 32.
    Olawaiye A, Nithiam-Leitch M, Danakas G et al (2005) Mastalgia: a review of management. J Reprod Med 50(19):933–939PubMedGoogle Scholar
  33. 33.
    Tumhan L, Hoyt AC, Bassett LW (2005) Negative predictive value of sonography and mammography in patients with focal breast pain. Breast J 11(5):333–337CrossRefGoogle Scholar
  34. 34.
    Kneece J (2003) Noncyclic pain. In: Kneece J (ed) Solving the mystery of breast pain, 2nd edn. Educare Publishing, Columbia, SC, pp 37–39Google Scholar
  35. 35.
    Khan HN, Rampaul R, Blabey RW (2004) Local anaesthetic and steroid combined injection therapy in the management of noncyclic mastalgia. Breast 13(2):129–132PubMedCrossRefGoogle Scholar
  36. 36.
    Fentimen I (2004) Management of breast pain. In: Harris JR, Lippman ME, Morrow M, Osborne CL (eds) Diseases of the breast, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, PA, pp 57–61Google Scholar
  37. 37.
    Kneece J (2003) Noncyclic pain. In: Kneece J (ed) Solving the mystery of breast pain, 2nd edn. Educare Publishing, Columbia, SC, p 40Google Scholar
  38. 38.
    Rosolowich V, Saettler E, Szuck B et al (2006) Mastalgia. J Obstet Gynaecol Can 28(1):49–74PubMedGoogle Scholar
  39. 39.
    Srivastava A, Mansel RE, Arvind N et al (2007) Evidence-based management of mastalgia: a meta-analysis of randomized trials. Breast 16(5):503–512PubMedCrossRefGoogle Scholar
  40. 40.
    Quereshi S, Sultan N (2005) Topical nonsteroidal anti-inflammatory drugs versus oil of evening primrose in the treatment of mastalgia. J R Coll Surg Edinb Ireland 3(11):7–10CrossRefGoogle Scholar
  41. 41.
    Colak T, Ipek T, Kanik A et al (2003) Efficacy of topical nonsteroidal anti-inflammatory drugs in mastalgia treatment. J Am Coll Surg 196(4):525–530PubMedCrossRefGoogle Scholar
  42. 42.
    Rosen PP (1997) Mammary duct ectasia. In: Rosen PP (ed) Rosen’s breast pathology. Lippincott-Raven, Philadelphia, PA, pp 29–32Google Scholar
  43. 43.
    Devitt JE (1996) Benign disorders of the breast in older women. Surg Gynecol Obstet 162:340–342Google Scholar
  44. 44.
    Heywang-Kobrunger SH, Scherer I, Dershaw DD (1997) Benign breast disorders. Thieme, Stuttgart, pp 141–165Google Scholar
  45. 45.
    Kern WH, Clark RW (1973) Retrogression of fibroadenomas of the breast. Am J Surg 126:56–59CrossRefGoogle Scholar
  46. 46.
    Hunter TB, Roberts CC, Hunt R et al (1996) Occurrence of fibroadenomas in postmenopausal women referred for breast biopsy. J Am Geriatr Soc 44:61–64PubMedGoogle Scholar
  47. 47.
    Dixon JM (1991) Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk. Br Med Bull 47:258–271PubMedGoogle Scholar
  48. 48.
    Egan R (1988) Fibroadenoma. In: Egan R (ed) Breast imaging. Diagnosis and morphology of breast diseases. Saunders, Philadelphia, PA, pp 178–182Google Scholar
  49. 49.
    Kopans DB (1988) Benign and probably benign lesions. In: Kopans DB (ed) Breast imaging. Lippincott-Raven, Philadelphia, PA, pp 351–373Google Scholar
  50. 50.
    Peck DR, Lowman RM (1978) Estrogen and the postmenopausal breast: mammographic considerations. JAMA 240:1733–1735PubMedCrossRefGoogle Scholar
  51. 51.
    Kaewrudee S, Anuwatnavin S, Kanpittaya J et al (2007) Effect of estrogen-progestin and estrogen on mammographic density. J Reprod Med 52(6):513–520PubMedGoogle Scholar
  52. 52.
    Aiello EJ, Buist DS, White E (2006) Do breast cancer risk factors modify the association between hormone therapy and mammographic density? Cancer Causes Control 17(10):1227–1235PubMedCrossRefGoogle Scholar
  53. 53.
    Laya MB, Larson EB, Taplin SH et al (1996) Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88(10):643–649PubMedCrossRefGoogle Scholar
  54. 54.
    Crandall CJ, Karlamangla A, Huang MH et al (2006) Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy. Arch Int Med 166(15):1578–1584CrossRefGoogle Scholar
  55. 55.
    Carney PA, Kasales CJ, Tosteson AN et al (2004) Likelihood of additional work-up among women undergoing routine screening mammography: the impact of age, breast density, and hormone therapy use. Prev Med 39(1):48–55PubMedCrossRefGoogle Scholar
  56. 56.
    Rutter CM, Mandelson MT, Laya MB et al (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 285(2):171–176PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Internal MedicineGreenwich HospitalGreenwichUSA

Personalised recommendations